Immtech Pharmaceuticals, Inc.

Scientific Consortium

in pursuit
of cures
Immtech enjoys a close partnership with a group of talented and dedicated scientists who have spent their careers in pursuit of cures.

Immtech Pharmaceuticals has an alliance with a consortium of universities and research
institute laboratories. This gives us access to accomplished scientists and development
teams whose members contribute to the discovery and development of compounds in our
medicinal chemistry library.

Two of our most widely published and respected lead scientists, Dr. Richard Tidwell and
Dr. David Boykin, have attracted a cadre of other renowned scientists to the consortium.
Together, they offer a depth of research knowledge and capabilities rivaled only by large,
multifaceted pharmaceutical companies.

Our scientists include:

Richard R. Tidwell, PhD
Head of Research
Director of the Research Consortium,
Chairman of the Scientific Advisory Board
- BIO

David W. Boykin, PhD
Regents’ Professor Emeritus of Chemistry,
Georgia State University
- BIO

Byron L. Blagburn, PhD
Alumni Professor
Department of Pathobiology
Auburn University
- BIO

Christine C. Dykstra, PhD
Associate Professor
Pathobiology Department
Auburn University, College of Veterinary Medicine
- BIO

Scott M. Franzblau, PhD
University of Illinois at Chicago
- BIO

James E. Hall, PhD
Associate Professor
UNC-CH School of Medicine
- BIO

John R. Perfect, M.D.
Associate Professor of Microbiology
Duke Medical Center

Dr. Perfect received his B.A. in Biology from Wittenberg University,
Springfield, Ohio in 1971 and his M.D. degree in Medicine from the
Medical College of Ohio at Toledo in 1974. Following an Internship at
Riverside Methodist Hospital in Columbus, OH, a Medical Residency
at the University of Michigan Medical Center, in Ann Arbor, MI and a
Fellowship in Infectious Diseases at Duke Medical Center in Durham,
NC, he joined the faculty at Duke University in 1982. He is currently a
Professor of Medicine at Duke University. Dr. Perfect’s Board
Certifications include the National Board of Medical Examiners (1974),
American Board of Internal Medicine (1977), and American Board of
Infectious Diseases (1980). Dr. Perfect’s research focuses on
molecular targets of aromatic dicationic drugs in fungi.